{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T23:23:11Z","timestamp":1781220191224,"version":"3.54.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":2821,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1016\/j.jcf.2005.09.003","type":"journal-article","created":{"date-parts":[[2005,10,21]],"date-time":"2005-10-21T11:13:45Z","timestamp":1129893225000},"page":"221-225","source":"Crossref","is-referenced-by-count":34,"title":["The effects of intravenous tobramycin on renal tubular function in children with cystic fibrosis"],"prefix":"10.1016","volume":"4","author":[{"given":"S.","family":"Glass","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.D.","family":"Plant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.A.","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2005.09.003_bib1","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3109\/08860229209106642","article-title":"Drug\u2013phospholipid interactions","volume":"14","author":"Kaloyanides","year":"1992","journal-title":"Ren Fail"},{"key":"10.1016\/j.jcf.2005.09.003_bib2","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/S0046-8177(82)80056-7","article-title":"The nephropathy of cystic fibrosis: a human model of chronic nephrotoxicity","volume":"13","author":"Abramowsky","year":"1982","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jcf.2005.09.003_bib3","series-title":"Diseases of the kidney","first-page":"1131","article-title":"Aminoglycoside nephrotoxicity","author":"Kaloyanides","year":"1992"},{"key":"10.1016\/j.jcf.2005.09.003_bib4","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0300-483X(82)90092-0","article-title":"Urinary enzymes, nephrotoxicity and renal disease","volume":"23","author":"Price","year":"1982","journal-title":"Toxicology"},{"key":"10.1016\/j.jcf.2005.09.003_bib5","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1542\/peds.62.5.751","article-title":"Enzymuria as a marker of renal injury and disease: studies of N-acetyl-beta-glucosaminidase in the general population and in patients with renal disease","volume":"62","author":"Kunin","year":"1978","journal-title":"Pediater"},{"key":"10.1016\/j.jcf.2005.09.003_bib6","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1177\/000456328702400509","article-title":"Retinol binding protein as a small molecular weight marker of renal tubular dysfunction in diabetes mellitus","volume":"24","author":"Rowe","year":"1987","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.jcf.2005.09.003_bib7","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1651-2227.1999.tb00044.x","article-title":"Aminoglycoside-associated hypomagnesaemia in children with cystic fibrosis","volume":"88","author":"Akbar","year":"1999","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.jcf.2005.09.003_bib8","series-title":"Pediatrics Update","first-page":"265","article-title":"The nephrotoxicity of antimicrobial drugs","author":"Prime","year":"1981"},{"key":"10.1016\/j.jcf.2005.09.003_bib9","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1542\/peds.58.2.259","article-title":"A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine","volume":"58","author":"Schwartz","year":"1976","journal-title":"Pediater"},{"key":"10.1016\/j.jcf.2005.09.003_bib10","first-page":"280","article-title":"N-acetyl-beta-d-glucosaminidase (NAG) im Urin. Ein zusatzlicher Parameter zur Lokalisa-tionsdiagnostik eines Harnwegsinfekts","volume":"137","author":"Ring","year":"1989","journal-title":"Monatsschr Kinderheilkd"},{"key":"10.1016\/j.jcf.2005.09.003_bib11","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/BF02429057","article-title":"Renal function in cystic fibrosis: proteinuria and enzymuria before and after tobramycin therapy","volume":"145","author":"Steinkamp","year":"1986","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jcf.2005.09.003_bib12","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/978-1-4684-8953-8_22","article-title":"Aminoglycoside nephrotoxicity: mechanism and prevention","volume":"252","author":"De Broe","year":"1989","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jcf.2005.09.003_bib13","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3109\/00365528809090220","article-title":"Investigation of aminoglycoside nephrotoxicity in cystic fibrosis patients","volume":"143","author":"Godson","year":"1988","journal-title":"Scand J Gastroenterol Suppl"},{"key":"10.1016\/j.jcf.2005.09.003_bib14","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1136\/adc.78.6.540","article-title":"Urinary N-acetyl-beta-d-glucosaminidase activity in patients with cystic fibrosis on long-term gentamicin inhalation","volume":"78","author":"Ring","year":"1998","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jcf.2005.09.003_bib15","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0140-6736(05)17906-9","article-title":"Once versus three-times daily regimens of tobramycin treatment for pulmonary exacerbations of cystic fibrosis\u2014the TOPIC study: a randomised controlled trial","volume":"365","author":"Smyth","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jcf.2005.09.003_bib16","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1378\/chest.122.1.219","article-title":"Pharmacokinetics and bioavailability of aerosolized tobramycin in cystic fibrosis","volume":"122","author":"Geller","year":"2002","journal-title":"Chest"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199305001189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199305001189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T05:23:27Z","timestamp":1683264207000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199305001189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S1569199305001189"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2005.09.003","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}